From Wikipedia, the free encyclopedia
 |
|
Formestane
|
| Systematic (IUPAC) name |
(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-
2,6,7,8,9,11,12,14,15,16-decahydro-1H-
cyclopenta[a]phenanthrene-3,17-dione |
| Identifiers |
| CAS number |
566-48-3 |
| ATC code |
L02BG02 |
| PubChem |
11273 |
| Chemical data |
| Formula |
C19H26O3 |
| Mol. mass |
302.408 g/mol |
| Pharmacokinetic data |
| Bioavailability |
? |
| Metabolism |
? |
| Half life |
? |
| Excretion |
? |
| Therapeutic considerations |
| Pregnancy cat. |
?
|
| Legal status |
|
| Routes |
? |
Formestane belongs to a class of drugs known as aromatase inhibitors. It is used in the treatment of estrogen-receptor positive breast cancer in post-menopausal women. It is available as an intramuscular depot injection (Lentaron).
Formestane is often used to suppress estrogen production from anabolic steroids or prohormones. It also acts as a prohormone to 4-hydroxytestosterone, an active steroid which displays weak androgenic activity in addition to acting as a mild aromatase inhibitor.
Formestane has poor oral bioavailability and as such is no longer popular as many orally available aromatase inhibitors have been developed.
|
Sex hormones and related agents (primarily G03, also L02, H01C) - human endogenous in CAPS |
|
Progestogens:
(receptor) |
PROGESTERONE, Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, Gestonorone, Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, Tibolone
Selective progesterone receptor modulator: Asoprisnil, CDB-4124
Antiprogestogen: Mifepristone
|
|
Androgens:
(receptor) |
TESTOSTERONE, Androstanolone, Fluoxymesterone, Mesterolone, Methyltestosterone, (see also anabolic steroids)
Antiandrogens: Bicalutamide, Cyproterone, Dienogest, Flutamide, Nilutamide, Spironolactone
|
|
Estrogens:
(receptor) |
ESTRADIOL, ESTRIOL, ESTRONE, Chlorotrianisene, Dienestrol, Diethylstilbestrol, Ethinylestradiol, Fosfestrol, Mestranol, Polyestradiol phosphate
Selective estrogen receptor modulator: Afimoxifene, Arzoxifene, Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, Toremifene
Aromatase inhibitor: Aminogluthetimide, Anastrozole, Atamestane, Exemestane, Formestane, Letrozole, Vorozole
|
|
Gonadotropins:
(FSHR/LHCGR) |
|
|
GnRH:
(receptor) |
|
|